Ftse Mib
33.968,78
1,01%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.460,35
-0,84%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Bivictrix Therapeutics Plc (BVX) Bivictrix Therapeutics Plc (BVX) Notizie

Bivictrix Therapeutics Plc

BVX
11,50
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
17/4/202415:23ALNCNewsBivictrix granted FDA orphan drug status for rare cancer..
17/4/202408:00LSEG_RNSBiVictriX Therapeutics PLC Orphan Drug Designation & FDA..
28/3/202408:00LSEG_RNSBiVictriX Therapeutics PLC Grant of Options – PDMR/Director..
04/1/202413:30UKREGBiVictriX Therapeutics PLC Holding(s) in Company
04/1/202413:30UKREGBiVictriX Therapeutics PLC Holding(s) in Company
04/1/202408:00UKREGBiVictriX Therapeutics PLC BiVictriX Hosts Inaugural..
05/12/202312:08UKREGBiVictriX Therapeutics PLC Board Change
30/11/202313:08ALNCNewsIN BRIEF: Bivictrix selects final sequences for lead tumour..
30/11/202308:00UKREGBiVictriX Therapeutics PLC Pipeline update on BVX002
22/11/202318:14UKREGBiVictriX Therapeutics PLC Holding(s) in Company
15/11/202314:05ALNCNewsTRADING UPDATES: BiVictriX patent boost; 4Global deal..
15/11/202308:00UKREGBiVictriX Therapeutics PLC Patent Granted in Japan
12/10/202313:04ALNCNewsBivictrix says BVX001 increases survival rates by more than..
12/10/202308:00UKREGBiVictriX Therapeutics PLC Extended Survival Rates Reported..
03/10/202313:06ALNCNewsBivictrix hires new CFO as Alex Hughes steps down after..
03/10/202308:00UKREGBiVictriX Therapeutics PLC Appointment of Adrian Howd as CFO..
19/9/202318:30ALNCNewsTRADING UPDATES: AEW UK REIT appoints new chair; Oberon..
19/9/202308:00UKREGBiVictriX Therapeutics PLC Interim Results
31/8/202308:00UKREGBiVictriX Therapeutics PLC Total Voting Rights
23/8/202310:30ALNCNewsBivictrix Therapeutics granted US patent for cancer drug..
23/8/202308:00UKREGBiVictriX Therapeutics PLC US Patent Granted
17/8/202308:00UKREGBiVictriX Therapeutics PLC Holding(s) in Company
16/8/202319:00UKREGBiVictriX Therapeutics PLC Holding(s) in Company
11/8/202317:17UKREGBiVictriX Therapeutics PLC Holding(s) in Company
08/8/202318:18UKREGBiVictriX Therapeutics PLC Result of General Meeting
19/7/202320:30ALNCNewsUPDATE: Bivictrix Therapeutics raises GBP2.1 million through..
19/7/202319:16UKREGBiVictriX Therapeutics PLC Result of Conditional Fundraise
19/7/202315:12ALNCNewsIN BRIEF: Bivictrix to raise more than GBP2 million via..
19/7/202313:31UKREGBiVictriX Therapeutics PLC Proposed Fundraise in excess of..
17/7/202314:57ALNCNewsBivictrix Therapeutics hails positive data in final..
17/7/202308:00UKREGBiVictriX Therapeutics PLC Positive final data in..
19/6/202314:50ALNCNewsIN BRIEF: Bivictrix Therapeutics hails positive leukaemia..
19/6/202308:00UKREGBiVictriX Therapeutics PLC Positive interim data
06/6/202314:52ALNCNewsIN BRIEF: Bivictrix selects clinical candidate for leukaemia..
06/6/202308:00UKREGBiVictriX Therapeutics PLC BiVictriX nominates clinical..
Apertura: 11,50 Min: 11,50 Max: 11,50
Chiusura: 11,50

La tua Cronologia

LSE
BVX
Bivictrix Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network